Iboga's name derives from a psychoactive plant from Central Africa (Ibogaine Tabernanthe) which was used to rehabilitate heroin and cocaine …
Psychedelic Medicine Leader Expands Clinical Trials, Reports $11.4M Cash Position
Psyence BioMed (NASDAQ: PBM) provided a comprehensive corporate update highlighting significant progress across multiple fronts. The company reported a strong cash position of $11.4 million with no outstanding debt and successfully regained Nasdaq compliance following a 1-for-7.97 reverse stock split.
Key developments include protocol amendments to expand patient eligibility in clinical trials, activation of three ...
Psychedelic Therapy for Athletes – Leaf Nation
Robert Gallery isn’t your typical psychedelics user.
The 6-foot-7-inch retired NFL lineman isn’t your typical anything, for that matter. But as the founder of Athletes for Care — a nonprofit dedicated to research and developing pathways for athletes to use psychedelics to heal physical and emotional trauma — the former Raider and Seahawk wants more people to experience the power of psychedelic plant medicine.
“I was not experienced in the plant medicine space and psychedelics,” ...
Psyence Biomedical Shares Soar 70% Following Partner's Ibogaine Extraction Breakthrough – MSN
The partner successfully produced a GMP-compliant Ibogaine Total Alkaloid extract, marking a breakthrough in the scalable manufacturing of purified …
Psyence BioMed's Strategic Collaboration with PsyLabs Yields Breakthrough in High-Purity …
… Ibogaine HCL, Psilocybin Isolate, and other 90% purity SKUs, derived from both Iboga and Mushrooms. PsyLabs' Ibogaine will be available to …